国: ベルギー
言語: 英語
ソース: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose; Diphtheria Toxoid (DT) >= 30 IU; Tetanus Toxoid >= 40 IU; Aluminium Hydroxide 0,3 mg; Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Bordetella Pertussis Toxoid (PT) 25 µg; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg
Sanofi Pasteur Europe S.A.
J07CA02
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Suspension for injection
Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins
Intramuscular use
Diphtheria-Pertussis-Poliomyelitis-Tetanus
CTI code: 196122-01 - Pack size: 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 196122-02 - Pack size: 0.5 ml - Commercialisation status: YES - FMD code: 03664798005219 - CNK code: 2231868 - Delivery mode: Medical prescription; CTI code: 196122-03 - Pack size: 0.5 ml + 1 x Injection needle - Commercialisation status: NO - Delivery mode: Medical prescription; 196122-04; 196122-05; 196122-06
Commercialised: Yes
1998-11-03